[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$spry

$SPRY's Neffy receives Japan approval, but faces criticism for actions against competitors. Investors are concerned about the company's actions, causing mixed sentiment.

About $spry

A pharmaceutical company focused on allergy treatments, specifically epinephrine nasal spray.

Insights #

$spry engagements is up XXXXX% from the previous week.
$spry posts created is up XXXXX% from the previous week.

Engagements: XXX #

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXXXXX
1 Week: XXXXX +17%
1 Month: XXXXXX -XX%
1-Year High: XXXXXXX on 2025-05-27
1-Year Low: XX on 2025-10-10

Social Network	X
Engagements	XXX

Mentions: XX #

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
1 Month: XX -XX%
1-Year High: XXX on 2025-06-27
1-Year Low: X on 2025-10-10

Social Network	X
Mentions	XX

Creators: XX #

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning $spry in the last XX hours which is up XX% from XX in the previous XX hours Daily Average: XX
1 Month: XX -XX%
1-Year High: XXX on 2025-06-27
1-Year Low: X on 2025-10-10

The most influential creators that mention $spry in the last XX hours

Creator	Rank	Followers	Posts	Engagements
@BiopharmIQ	X	XXXXXX	X	XXX
@AllenWoodMBA	X	XXX	X	XX

Sentiment: XX% #

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% -XX%
1 Month: XX% +2%
1-Year High: XXX% on 2025-04-27
1-Year Low: XX% on 2025-09-26

Most Supportive Themes

Approval and Expansion: (35%) Positive sentiment surrounds the recent approval of $SPRY's Neffy in Japan and its potential for global expansion.

Most Critical Themes

Competition and Legal Challenges: (60%) Concerns and criticism arise from $SPRY's actions against competitors, particularly regarding the FDA petition to delay approval of Anaphylm.

Network engagement breakdown:

Network	Positive	%	Neutral	%	Negative	%
X	XXX	XX%	XXX	XX%	XX	X%

Total	XXX	XX%	XXX	XX%	XX	X%

Top assets mentioned In the posts about $spry in the last XX hours

Denali Therapeutics Inc. Common Stock (DNLI) Twist Bioscience Corporation Common Stock (TWST) Agios Pharmaceuticals, Inc. (AGIO) CG Oncology, Inc. Common stock (CGON) Oklo Inc. (OKLO) Rigetti Computing, Inc. Common Stock (RGTI) Levi Strauss & Co. Class A Common Stock (LEVI) Kenvue Inc. (KVUE) Lululemon Athletica Inc (LULU) Chipotle Mexican Grill, Inc. (CMG)

Top topics mentioned In the posts about $spry in the last XX hours

$aqst, stocks consumer cyclical, coins defi, rescue, stocks healthcare, approved, stocks financial services, has been, $knsa, $dnli, $twst, $agio, $cgon, stocks technology, $oklo, $rgti, $levi, $orxst, spikes, med, $kvue, $lulu, $cmg, $oke, debt, tencent, $0700hk, $tcehy, $eongy, lenovo, $rytm, $ewtx, $onc, $incy, stocks consumer defensive, $uaa, amcor plc, $amcr, $urgn, $sndx, dawn protocol, coins nft, $cety, $nasdaq, coins bsc, doge jones industrial average, coins solana ecosystem, $evax, $atxs, $lsta, $aard, $2b, about to, $240m, $sdot, $pcsa, $cmnd, $sera, coins dao, quarterly earnings, atr aptargroup inc, decent, the only, $teva, $pipr, all the, $sprys, $argx, $184k, $1437k, $183k, morgan stanley, $kvyo, $ntsk, $lnc, mergers and acquisitions, $oxy, $dkng, $mara